Detailed answers about GAMMADELTA THERAPEUTICS LTD, including incorporation, status, business activity, and accounts information.
When was GAMMADELTA THERAPEUTICS LTD founded?
GAMMADELTA THERAPEUTICS LTD was officially incorporated on 17 June 2016 and is registered under company number 10238425. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is GAMMADELTA THERAPEUTICS LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of GAMMADELTA THERAPEUTICS LTD?
GAMMADELTA THERAPEUTICS LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does GAMMADELTA THERAPEUTICS LTD do?
GAMMADELTA THERAPEUTICS LTD operates in the following sector: 72110 - Research and experimental development on biotechnology. This provides insight into the company's primary business activity and industry focus.
What is GAMMADELTA THERAPEUTICS LTD's registered address?
The registered office address of GAMMADELTA THERAPEUTICS LTD is 1 KINGDOM STREET, LONDON, ENGLAND, W2 6BD. This is the official address filed with Companies House for legal and statutory correspondence.
Is GAMMADELTA THERAPEUTICS LTD financially stable?
The most recent accounts for GAMMADELTA THERAPEUTICS LTD were made up to 31 March 2024, filed as FULL. Next accounts are due by 31 March 2026.
Does GAMMADELTA THERAPEUTICS LTD have any charges or mortgages?
GAMMADELTA THERAPEUTICS LTD has 1 registered charge, of which 0 are outstanding, 1 satisfied, and 0 part satisfied. Charges are typically registered when a company uses its assets as security for borrowing.